We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHCG
2601
DELISTED
LHC Group LLC
LHCG
$526K ﹤0.01%
4,400
-160
-4% -$18K
BCRH
2602
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$526K ﹤0.01%
79,806
-17,692
-18% -$125K
PKO
2603
DELISTED
Pimco Income Opportunity Fund
PKO
$526K ﹤0.01%
19,420
-1,060
-5% -$28.3K
PXF icon
2604
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.96B
$525K ﹤0.01%
12,927
-4,289
-25% -$175K
CTRA
2605
DELISTED
Coterra Energy
CTRA
$524K ﹤0.01%
22,810
-11,846
-34% -$302K
JELD icon
2606
JELD-WEN Holding
JELD
$169M
$524K ﹤0.01%
24,671
+396
+2% +$7.98K
KRO icon
2607
KRONOS Worldwide
KRO
$998M
$524K ﹤0.01%
34,215
+6,890
+25% +$95.6K
PRGS icon
2608
Progress Software
PRGS
$1.78B
$524K ﹤0.01%
12,008
+4,549
+61% +$197K
BFK
2609
DELISTED
BlackRock Municipal Income Trust
BFK
$523K ﹤0.01%
37,595
+2,620
+7% +$36.4K
BCSF icon
2610
Bain Capital Specialty
BCSF
$847M
$522K ﹤0.01%
+28,573
New +$543K
MTRN icon
2611
Materion
MTRN
$5.87B
$521K ﹤0.01%
7,686
-4,750
-38% -$299K
JTD
2612
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
$521K ﹤0.01%
31,334
+14,089
+82% +$228K
SSYS icon
2613
Stratasys
SSYS
$775M
$520K ﹤0.01%
17,695
-1,007
-5% -$23.9K
INST
2614
DELISTED
Instructure, Inc.
INST
$519K ﹤0.01%
12,219
-1,443
-11% -$62.4K
NGHC
2615
DELISTED
National General Holdings Corp
NGHC
$518K ﹤0.01%
22,574
-434
-2% -$10.4K
UNT
2616
DELISTED
UNIT Corporation
UNT
$518K ﹤0.01%
58,250
+8,978
+18% +$104K
TSE
2617
DELISTED
Trinseo
TSE
$516K ﹤0.01%
12,195
-35,884
-75% -$1.54M
OTTR icon
2618
Otter Tail
OTTR
$3.9B
$515K ﹤0.01%
+9,760
New +$497K
SLGL icon
2619
Sol-Gel Technologies
SLGL
$275M
$515K ﹤0.01%
5,631
+1,525
+37% +$122K
GGN
2620
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$834M
$514K ﹤0.01%
112,309
+384
+0.3% +$1.69K
SAIL
2621
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$513K ﹤0.01%
25,588
+6,738
+36% +$153K
IGE icon
2622
iShares North American Natural Resources ETF
IGE
$783M
$512K ﹤0.01%
16,667
+218
+1% +$6.67K
BGY icon
2623
BlackRock Enhanced International Dividend Trust
BGY
$533M
$511K ﹤0.01%
90,937
+9,868
+12% +$54.5K
MOO icon
2624
VanEck Agribusiness ETF
MOO
$978M
$510K ﹤0.01%
7,630
+206
+3% +$13.1K
SBR
2625
Sabine Royalty Trust
SBR
$1.06B
$510K ﹤0.01%
10,545
+751
+8% +$36.3K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.